Patents by Inventor Robert B. McCall

Robert B. McCall has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10526405
    Abstract: An IL-31 dog pruritus model is provided. This model comprises administering canine IL-31 to dogs to produce a pruritic response; quantitatively measuring pruritic responses in the dogs which were administered canine IL-31; administering a candidate dog IL-31 inhibitor; and assessing the effectiveness of the candidate dog IL-31 inhibitor in reducing prurtic behavior in the treated dogs by challenging the dogs with canine IL-31 following the administration of the candidate dog IL-31 inhibitor.
    Type: Grant
    Filed: August 14, 2019
    Date of Patent: January 7, 2020
    Assignee: Zoetis Services LLC
    Inventors: Donald Wayne Mann, James Taylor Curry, Robert B. McCall, William R. Humphrey, Andrea Joy Gonzales, Gary Francis Bammert, Steven Alan Dunham
  • Publication number: 20190359702
    Abstract: An IL-31 dog pruritus model is provided. This model comprises administering canine IL-31 to dogs to produce a pruritic response; quantitatively measuring pruritic responses in the dogs which were administered canine IL-31; administering a candidate dog IL-31 inhibitor; and assessing the effectiveness of the candidate dog IL-31 inhibitor in reducing prurtic behavior in the treated dogs by challenging the dogs with canine IL-31 following the administration of the candidate dog IL-31 inhibitor.
    Type: Application
    Filed: August 14, 2019
    Publication date: November 28, 2019
    Inventors: DONALD WAYNE MANN, JAMES TAYLOR CURRY, ROBERT B. MCCALL, WILLIAM R. HUMPHREY, ANDREA JOY GONZALES, GARY FRANCIS BAMMERT, STEVEN ALAN DUNHAM
  • Patent number: 6921771
    Abstract: The present invention is a method of treating sexual disturbances in humans and inducing mating in non-human mammals using the compounds of formula (A) in a dosage range where the sexually therapeutic amount is from about 0.2 thru 8 mg/person/dose and where the sexually mating amount is from about 0.003 thru 0.2 mg/kg/dose.
    Type: Grant
    Filed: February 19, 2002
    Date of Patent: July 26, 2005
    Assignee: Pharmacia & Upjohn Company
    Inventors: Robert B. McCall, Martin Durham Meglasson
  • Patent number: 6903127
    Abstract: The present invention is a method of treating sexual disturbances in humans and inducing mating in non-human mammals using the compounds of formula (A) in a dosage range where the sexually therapeutic amount is from about 0.2 thru 8 mg/person/dose and where the sexually mating amount is from about 0.003 thru 0.2 mg/kg/dose.
    Type: Grant
    Filed: July 30, 2002
    Date of Patent: June 7, 2005
    Assignee: Pharmacia & Upjohn Company
    Inventors: Robert B. McCall, Martin Durham Meglasson
  • Patent number: 6890945
    Abstract: The present invention is a method of treating sexual disturbances in humans and inducing mating in non-human mammals using the compounds of formula (A) in a dosage range where the sexually therapeutic amount is from about 0.2 thru 8 mg/person/dose and where the sexually mating amount is from about 0.003 thru 0.2 mg/kg/dose.
    Type: Grant
    Filed: July 30, 2002
    Date of Patent: May 10, 2005
    Assignee: Pharmacia & Upjohn Company
    Inventors: Robert B. McCall, Martin Durham Meglasson
  • Publication number: 20040214824
    Abstract: The present invention is a method of treating sexual disturbances in humans and inducing mating in non-human mammals using the compounds of formula (A) 1
    Type: Application
    Filed: May 24, 2004
    Publication date: October 28, 2004
    Applicant: Pharmacia & Upjohn Company
    Inventors: Robert B. McCall, Martin Durham Meglasson
  • Publication number: 20040214825
    Abstract: The present invention is a method of treating sexual disturbances in humans and inducing mating in non-human mammals using the compounds of formula (A) 1
    Type: Application
    Filed: May 24, 2004
    Publication date: October 28, 2004
    Applicant: Pharmacia & Upjohn Company
    Inventors: Robert B. McCall, Martin Durham Meglasson
  • Publication number: 20040214823
    Abstract: The present invention is a method of treating sexual disturbances in humans and inducing mating in non-human mammals using the compounds of formula (A) 1
    Type: Application
    Filed: May 14, 2004
    Publication date: October 28, 2004
    Applicant: Pharmacia & Upjohn Company
    Inventors: Robert B. McCall, Martin Durham Meglasson
  • Patent number: 6809112
    Abstract: The present invention is a method of treating sexual disturbances in humans and inducing mating in non-human mammals using the compounds of formula (A) in a dosage range where the sexually therapeutic amount is from about 0.2 thru 8 mg/person/dose and where the sexually mating amount is from about 0.003 thru 0.2 mg/kg/dose.
    Type: Grant
    Filed: July 30, 2002
    Date of Patent: October 26, 2004
    Assignee: Pharmacia & Upjohn Company
    Inventors: Robert B. McCall, Martin Durham Meglasson
  • Publication number: 20030212085
    Abstract: The present invention relates to the treatment of neuromuscular disorders and, more specifically, to the use of apomorphine, bromocriptine, pergolide, ropinirole, octahydropyrazolo[3,4-g]quinolines, and trans-(±)-substituted-5,5a,6,7,8,9-,9a,10-octahydropyrimido[4,5g]quinolines, and their pharmaceutically acceptable salts to treat, or to prepare a medicament for treating, symptoms of fibromyalgia syndrome and chronic fatigue syndrome.
    Type: Application
    Filed: October 18, 2002
    Publication date: November 13, 2003
    Inventors: Robert B. McCall, Robert Clyde Marshall
  • Publication number: 20030191149
    Abstract: The present invention provides for methods for the treatment of fibromyalgia syndrome or chronic fatigue syndrome by the administration of heterocyclic amine-type compounds, substituted phenylazacycloalkane-type compounds, or cabergoline-type compounds, or a salt of any said compound.
    Type: Application
    Filed: March 7, 2003
    Publication date: October 9, 2003
    Inventors: Robert B. McCall, Robert Clyde Marshall, David W. Robertson, Thomas M. Ashley
  • Patent number: 6555548
    Abstract: The present invention provides for methods for the treatment of fibromyalgia syndrome or chronic fatigue syndrome by the administration of cabergoline-type compounds or a salt of said compound.
    Type: Grant
    Filed: May 30, 2002
    Date of Patent: April 29, 2003
    Assignee: Pharmacia & Upjohn Company
    Inventors: Robert B. McCall, Robert Clyde Marshall, David W. Robertson, Thomas M. Ashley
  • Publication number: 20030013710
    Abstract: The present invention is a method of treating sexual disturbances in humans and inducing mating in non-human mammals using the compounds of formula (A) 1
    Type: Application
    Filed: July 30, 2002
    Publication date: January 16, 2003
    Inventors: Robert B. McCall, Martin Durham Meglasson
  • Publication number: 20030004152
    Abstract: The present invention is a method of treating sexual disturbances in humans and inducing mating in non-human mammals using the compounds of formula (A) 1
    Type: Application
    Filed: July 30, 2002
    Publication date: January 2, 2003
    Inventors: Robert B. McCall, Martin Durham Meglasson
  • Publication number: 20020198187
    Abstract: The present invention is a method of treating sexual disturbances in humans and inducing mating in non-human mammals using the compounds of formula (A) 1
    Type: Application
    Filed: July 30, 2002
    Publication date: December 26, 2002
    Inventors: Robert B. McCall, Martin Durham Meglasson
  • Publication number: 20020143010
    Abstract: The present invention provides for methods for the treatment of fibromyalgia syndrome or chronic fatigue syndrome by the administration of heterocyclic amine-type compounds, substituted phenylazacycloalkane-type compounds, or cabergoline-type compounds, or a salt of any said compound.
    Type: Application
    Filed: May 30, 2002
    Publication date: October 3, 2002
    Inventors: Robert B. McCall, Robert Clyde Marshall, David W. Robertson, Thomas M. Ashley
  • Patent number: 6455564
    Abstract: The present invention is a method of treating sexual disturbances in humans and inducing mating in non-human mammals using the compounds of formula (A) in a dosage range where the sexually therapeutic amount is from about 0.2 thru 8 mg/person/dose and where the sexually mating amount is from about 0.003 thru 0.2 mg/kg/dose.
    Type: Grant
    Filed: December 17, 1999
    Date of Patent: September 24, 2002
    Assignee: Pharmacia & Upjohn Company
    Inventors: Martin Durham Meglasson, Robert B. McCall
  • Patent number: 6448258
    Abstract: The present invention provides for methods for the treatment of fibromyalgia syndrome or chronic fatigue syndrome by the administration of heterocyclic amine-type compounds or a salt of any said compound.
    Type: Grant
    Filed: April 17, 2001
    Date of Patent: September 10, 2002
    Assignee: Pharmacia & Upjohn Company
    Inventors: Robert B. McCall, Robert Clyde Marshall, David W. Robertson, Thomas M. Ashley
  • Publication number: 20020107247
    Abstract: The present invention is a method of treating sexual disturbances in humans and inducing mating in non-human mammals using the compounds of formula (A) 1
    Type: Application
    Filed: February 19, 2002
    Publication date: August 8, 2002
    Inventors: Robert B. McCall, Martin Durham Meglasson
  • Publication number: 20020004510
    Abstract: The present invention provides for methods for the treatment of fibromyalgia syndrome or chronic fatigue syndrome by the administration of heterocyclic amine-type compounds, substituted phenylazacycloalkane-type compounds, or cabergoline-type compounds, or a salt of any said compound.
    Type: Application
    Filed: April 17, 2001
    Publication date: January 10, 2002
    Inventors: Robert B. McCall, Robert Clyde Marshall, David W. Robertson, Thomas M. Ashley